Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | LY4050784 |
Synonyms | |
Therapy Description |
LY4050784 inhibits SMARCA2 (BRM) and SMARCA4 (BRG1), potentially leading to decreased tumor growth (Mol Cancer Ther (2024) 23 (6_Supplement): PR015). |